The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Cerebrospinal fluid biopterin and biogenic amine metabolites during oral R-THBP therapy for infantile autism
Abstract
Treatment with 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (R-THBP) has been suggested to improve autistic behavior. Cerebrospinal fluid (CSF) levels of total biopterin, oxidized and reduced forms of biopterin, homovanillic acid, and 5-hydroxyindoleacetic acid were measured in 14 autistic children and 18 controls to clarify the mechanism of action of R-THBP. The 14 autistic children received R-THBP orally at 1 mg/kg per day; 7 children showed clinical improvement (responders) and the other 7 patients did not (nonresponders). There were no significant differences between responders, nonresponders, and controls in the CSF levels of the metabolites before R-THBP administration. When lumbar puncture was repeated in 6 autistic children in the 24th week of R-THBP therapy, there was no significant change in the CSF levels of any metabolites.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“some studies have shown decreases or no change in sensitive markers of CNS immune activation — including quinolinic acid, neopterin and biopterin — in the cerebrospinal fluid (CSF) of individuals with ASD139–141.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [141]
In the citing paper
“increases in soluble TNF receptors that blunt the inflammatory response in the CSF and serum from individuals with ASD141.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [141]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders
&NA; (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00022 · Cited by 12,526
Diagnostic and Statistical Manual of Mental Disorders, 3rd ed
KENDELL, R. E. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.12.1630 · Cited by 5,189
Analysis of reduced forms of biopterin in biological tissues and fluids
Fukushima, T., & Nixon, J. C. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90336-x · Cited by 710
The Metabolic Basis of Inherited Disease
Garland, J. T. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440180133052 · Cited by 652
COMFREY HERB TEA AND HEPATIC VENO-OCCLUSIVE DISEASE
Ridker, P., & Mcdermott, W. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92154-5 · Cited by 206
SUCCESSFUL TREATMENT OF DEPRESSION WITH TETRAHYDROBIOPTERIN
Curtius, H. ‐., Niederwieser, A., Levine, R., Lovenberg, W. M., Woggon, B., & Angst, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91837-8 · Cited by 91
THE NEUROBIOLOGY OF INFANTILE AUTISM
Gillberg, C. (1988) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1988.tb00714.x · Cited by 72
Kaufman, S., Kapatos, G., Mclnnes, R. R., Schulman, J. D., & Rizzo, W. B. (1982) · PEDIATRICS · doi:10.1542/peds.70.3.376 · Cited by 70
Cerebrospinal Fluid Biopterin Is Decreased in Alzheimer's Disease
Kay, A. D., Milstien, S., Kaufman, S., Creasey, H. M., Haxby, J. V., Cutler, N. R., & Рапопорт, С. И. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520100018008 · Cited by 43
Therapeutic efficacy of tetrahydrobiopterin in Parkinson's disease.
Curtius, H., Niederwieser, A., Levine, R., & Müldner, H. (1984) · PubMed · Cited by 40
Eto, I., Bandy, M. D., & Butterworth, C. E. (1992) · Journal of Autism and Developmental Disorders · doi:10.1007/bf01058157 · Cited by 31
Fink, J. K., Ravin, P. D., Argoff, C. E., Levine, R. A., Brady, R. O., Hallett, M., & Barton, N. W. (1989) · Neurology · doi:10.1212/wnl.39.10.1393 · Cited by 30
Yokoo, H., Kojima, H., Yamada, S., Tsutsumi, T., Anno, N., Anraku, S., Nishi, S., & Inanaga, K. (1985) · The Kurume Medical Journal · doi:10.2739/kurumemedj.32.75 · Cited by 11
Self-citationFour adult Rett patients at an institution for the handicapped
Yano, S., Yamashita, Y., Matsuishi, T., Abe, T., Yamada, S., & Shinohara, M. (1991) · Pediatric Neurology · doi:10.1016/0887-8994(91)90047-o · Cited by 10
Self-citationRecent Neurobiological Findings in Autism
Tsai, L. Y. (1989) · Springer eBooks · doi:10.1007/978-1-4899-0882-7_7 · Cited by 9
Research works printed but not linked: 4
- Nakane, Y., Naruse, H., Takesada, M., & Yamazaki, K. (1992). Clinical effect of R-THBP on infantile autism. In H. Naruse and E. M. Ornitz (Eds.),Neurobiology of infantile autism (pp. 337–350). Amsterdam: Elsevier.
- Naruse, H., Hayashi, T., & Takesada, M. (1992). Biochemical studies on autistic children using deuterated or carbon-13 labeled aromatic amino acids. In H. Naruse and E. M. Ornitz (Eds.),Neurobiology of infantile autism (pp. 299–312). Amsterdam: Elsevier.
- Noguchi, T., Onuma, N., & Hayashi, T. (1987). Dynamics of R-THBP in the rat.1987 Report on new drug development (pp. 23–28), Japanese Ministry of Health and Welfare.
- Watanabe, Y., Miwa, S., Mataga, N., Imamura, K., Tani, Y., Koshimura, K., Ohue, T., Onoe, H., Watanabe, Y., Ishimura, T., Hartvig, P., Bjurling, P., Linder, K. J., Langström, B., Noguchi, T., & Hayashi, O. (1992). Basic study on 6R-tetrahydrobiopterin treatment for infantile autism and neuropsychiatric disorders. In H. Nause and E. M. Ornitz (Eds.),Neurobiology of infantile autism (pp. 317–332). Amsterdam: Elsvier.
Cited by
Rossignol, D. A., & Frye, R. E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.165 · Cited by 543
Immune mediators in the brain and peripheral tissues in autism spectrum disorder
Estes, M. L., & McAllister, A. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3978 · Cited by 514
Tetrahydrobiopterin: biochemistry and pathophysiology
Werner, E. R., Blau, N., & Thöny, B. (2011) · Biochemical Journal · doi:10.1042/bj20110293 · Cited by 493
Cerebrospinal Fluid and Serum Markers of Inflammation in Autism
Zimmerman, A. W., Jyonouchi, H., Comi, A. M., Connors, S. L., Milstien, S., Varsou, A., & Heyes, M. P. (2005) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2005.03.014 · Cited by 300
Novel and Emerging Treatments for Autism Spectrum Disorders: A Systematic Review
Rossignol, D. A. (2009) · Annals of Clinical Psychiatry · doi:10.1177/104012370902100404 · Cited by 162
Metadata
- Authors
- Komori, H., Matsuishi, T., Yamada, S., Yamashita, Y., Ohtaki, E., & Kato, H.
- Affiliations
- Kurume University (JP)
- Venue
- Journal of Autism and Developmental Disorders
- Published
- 1995-04
- Volume
- 25
- Issue
- 2
- Pages
- 183-193
- ISSN
- 0162-3257 (ISSN-L)
- 1573-3432
- OpenAlex
- W2328746533
- Cited by
- 21
- References
- 16
- Citations by year
- 2025: 2 · 2024: 2 · 2021: 1 · 2019: 1 · 2018: 1 · 2015: 1 · 2013: 1
- FWCI
- 0.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Autism and Developmental Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- infantile autism, cerebrospinal fluid, biopterin, homovanillic acid, 5-hydroxyindoleacetic acid, biogenic amine metabolites, treatment response, mechanism of action
- MeSH terms
- Autistic Disorder, Biopterins, Child, Child, Preschool, Female, Homovanillic Acid, Humans, Hydroxyindoleacetic Acid, Male, Personality Assessment, Treatment Outcome, Neurotransmitter Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.